SNOA — Sonoma Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $5.32m
- $0.12m
- $19.53m
Sonoma Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Sonoma Pharmaceuticals Inc expected to post a loss of 6 cents a share - Earnings Preview
Brief: Sonoma Pharmaceuticals Expands Negative-Pressure Wound Therapy Products In US
Sonoma Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Sonoma Pharmaceuticals Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Novabay Pharmaceuticals And Sonoma Pharmaceuticals Agree To Market Avenova-Branded Products In The European Union
Brief: Sonoma Pharmaceuticals Inc Files For Offering On Best Efforts Basis Up To 6.7 Million Shares Of Common Stock - SEC Filing
Brief: Sonoma Pharmaceuticals Inc Received Notice Of Delisting From Nasdaq
Brief: Sonoma Pharmaceuticals Inc Says Effective April 7, Chad White Resigned As CFO, And Board Appointed Jerry Dvonch As Interim CFO
Brief: Sonoma Pharmaceuticals Enters Into Exclusive Distribution Agreement With Daewoong Pharmaceutical Co
Brief: Sonoma Pharmaceuticals Enters Into At-The-Market Offering Agreement
Brief: Sonoma Pharmaceuticals Says Board Appointed Chad White As Interim CFO
Brief: Sonoma Pharmaceuticals Says Board Appointed CEO To Serve As A Member Of Board
U.S. STOCKS ON THE MOVE-Incyte Corp, Atkore Inc, Franklin Resources
U.S. STOCKS ON THE MOVE-Cummins Inc, Hasbro Inc, IonQ Inc
Sonoma Pharma surges on EPA approval for disinfectant
Brief: Sonoma Pharmaceuticals And Microsafe Group Dmcc Announce EPA Approval For Nanocyn® Hospital-Grade Disinfectant In The U.S.
U.S. STOCKS ON THE MOVE-Inspirato Inc, PVH Corp, Whirlpool Corp
Sonoma Pharma jumps on launching UTI treatment in three new markets